LINCODOX

The combination of doxycycline and lincomycin provides a broad-spectrum antibacterial
activity against most Gram-positive and Gram-negative micro-organisms including: Staphylococcus
spp. (including penicillinase producing strains), Streptococcus spp., Listeria monocytogenes,
Corynebacterium spp., Clostridium spp., Escherichia coli, Salmonella spp., Bacteroides spp.,
Enterobacter spp., Pasterella spp., Klebsiella spp., and also against Spirochetes spp., Mycoplasma spp.,
Treponema spp., Rickettsia spp., and Chlamydia psittaci.